Bioinspired surfaces against bacterial infections by Gomes, José et al.
Laureates: awards and Honors, sCs FaLL Meeting 2012 CHIMIA 2013, 67, Nr. 4 275
doi:10.2533/chimia.2013.275 Chimia 67 (2013) 275–278 © Schweizerische Chemische Gesellschaft
*Correspondence: J. Gomes
University of Basel
Department of Chemistry
St. Johanns-Ring 19
CH-4056 Basel
Tel.: +41 61 267 11 29
E-mail: jose.gomes@unibas.ch
Bioinspired Surfaces Against Bacterial
Infections
José Gomes
§
*, Alexander Grunau, Adrien K. Lawrence, Leo Eberl, and Karl Gademann
§
SCS-DSM Award for best poster presentation
Abstract: Bioactive surfaces that can prevent bacterial infections are of great interest since device-related
infections represent an emerging and major threat to our health-care system. For that purpose, dopamine and
its derivatives have been shown to provide an exceptionally facile method for the immobilization of bioactive
compounds on metal oxide surfaces through an operationally simple dip-and-rinse procedure. Based on this
method, three different coating strategies for the assembly of antifouling, antibacterial, and quorum sensing
modulating surfaces have been established. The anachelin chromophore and nitro-dopamine proved to be
very suitable anchoring moieties as they possess better oxidative stability and binding efficiency compared to
dopamine itself. Furthermore, adsorbed bioactive hybrids were shown to be stable and recycling of the surfaces
could be achieved. These examples clearly demonstrate the efficiency of this approach for the production of
active surfaces, such as in biomedical devices.
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Introduction
Health care-associated infections re-
main a devastating problem for patients
worldwide. Among these, bacterial infec-
tions of implantmaterials and devices, such
as catheters and stents, pose a major threat
to the quality of life of those affected.
[1,2]
Recent studies show that about half of
nosocomial infections are caused by such
device-associated infections.
[3]
Improved
procedures in sterilization, proper hygiene,
and operating techniques have much re-
duced the likeliness of an early stage in-
fection,
[4]
however, the infection rates that
occur weeks and months after surgery have
barely decreased. Such incidences mostly
occur due to the ability of bacteria to attach
to biomedical implants and thereby trigger
infections in the host, which are often not
detected at an early stage. In most cases,
the infections cannot be diagnosed before
damage has been caused to tissue and the
host organism. Upon adherence to the sur-
face,microorganismsgrowandaccumulate
in multilayered cell clusters, thereby form-
ing biofilms, which is considered to be the
first step in nosocomial infections.
[5,6]
In
this state, the developed bacterial biofilms
protect themselves against the host’s innate
immune system and even antibiotics by
generating an exocellular polysaccharide
matrix. A direct systematic treatment with
antibiotics is difficult due to reduced sus-
ceptibility of adherent bacteria, leading to
a several orders of magnitude decrease in
antibiotic efficacy.
[7,8]
Furthermore, the rise
of resistant bacterial strains constitutes an
additional challenge to be overcome.
[7–11]
As a result, current successful treatment
usually requires surgical replacement of
the infected devices, combined with pro-
longed intravenous and oral therapy with
antibiotics.
[12]
These complications not
only result in additional costs to the health
care system, but most importantly, also
lead to suffering of the patients and oc-
casionally to their death. Currently, about
30% of the hospitals in the US are using
antimicrobial catheters to prevent hospital-
acquired urinary tract infections.
[13]
The re-
lease of silver ions ismost likely preventing
the infection in these cases. However, the
usage of silver-containing medical devices
must be undertaken with caution since
silver has demonstrated a certain level of
toxicity to mammalian cells.
[14]
Therefore,
bioactive surfaces that can prevent infec-
tions of implants are currently the focus of
many research groups. Various techniques
have been established for the coating of
biomedical devices, including biopassive
and bioactive surfaces, with either a cova-
lently attached bioactive moiety or one that
is released into the surrounding periphery.
Despite of the elegance of these immobi-
lization techniques, some drawbacks have
to be overcome, such as limited stability or
range of substrate materials.
Bioinspired Adhesion
A particular challenge consists in the
development of coating agents that can
stronglybindactivecompounds tosurfaces.
Recently, catechols have been presented as
promising alternatives for the mild func-
tionalization of metal oxide surfaces.
[15–21]
The development of such anchors has
been inspired by the adhesive properties
of marine and freshwater mussels to all
kind of surfaces (Fig. 1). Mussels secrete
adhesion proteins (MAPs), which serve as
anchors and are responsible for the strong
Fig. 1. Mussels secrete proteins for adherence
to surfaces, such as TiO
2
.
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displayed excellent binding strength, but
also particularly oxidative stability when
compared to other dopamine derivatives
reported in the literature. Furthermore,
the readily available nitro-dopamine-PEG
conjugate (Fig. 3, top right) resulted in
comparable binding properties and oxi-
dative stability. It is noteworthy that even
though biofouling on biomedical devices
can be prevented by this approach, it has
the disadvantage that it cannot kill bacteria
upon exposure.
Antibacterial Coating
An appealing strategy to overcome this
problem is the incorporation or absorption
of antimicrobial agents onto or into the
implant surface. Such antibiotic surfaces
have the ability to actively kill bacteria up-
on contact or by slow release of the active
compounds into the local tissue.
[40]
The
immobilization of antibiotics usually re-
quires multiple chemical steps on the solid
surface and scale-up of these processes
can be problematic. In order to circum-
wet adhesion on surfaces.
[22,23]
MAPs have
been shown to contain up to 27% of the
posttranslationally modified amino acid
3,4-dihydroxyphenyl-l-alanine (DOPA),
which is the key constituent for adhesion
(Fig. 2). The usefulness of catechols as an-
choring groups for the functionalization of
surfaces has been extensively studied and
many different bioactive applications have
been established so far.
[21,24]
Even further,
many different catechol derivatives have
been studied and compared for their bind-
ing capacities, from which some of them
are shown in Fig. 2. Even though dopamine
and l-DOPA have been shown to be pow-
erful anchoring groups, they can easily be
oxidized and polymerize, rendering their
handling and storage inconvenient.
[25,26]
More stable catechol moieties can be
found in nature, such as the anachelin
chromophore, a cyanobacterial sidero-
phore.
[27,28]
In marine environments, iron
can become a growth-limiting nutrient
since its bioavailability is very low. That is
why some bacteria secrete anachelin into
their extracellular surroundings to bind and
sequester iron.
[29]
The quaternary aromatic
ammonium substituent present renders
this compound oxidatively more stable
and it was shown to exhibit superior bind-
ing properties compared to dopamine. A
purely chemical derivative that also dem-
onstrates good binding properties is nitro-
dopamine.
[25]
Even though nitro-dopamine
showed slightly weaker binding properties,
it is synthetically more easily accessible as
it can be prepared in a single step from the
commercially available and cheap dopa-
mine, in contrast to the anachelin chromo-
phore, which requires multiple synthetic
steps, involving heavy-metal-based
[30,31]
or enzymatic
[32,33]
conversions. Therefore,
we have been exploring these two anchor
moieties for the functionalization of tita-
nium dioxide (TiO
2
) surfaces. We chose to
utilize this metal oxide due to its biocom-
patibility and frequent application in the
field of medical devices. In this highlight
article, an overview of our recent develop-
ment in the field of catechol-based bioac-
tive surfaces against bacterial infections is
given, especially for the production of anti-
fouling, antibacterial, and quorum sensing
modulating surfaces.
Antifouling Coating
The unspecific adsorption of proteins
and microorganisms onto surfaces upon
their immersion in biological fluids has
been defined as biofouling.
[34]
Antifouling
materials have been the subject of much
interest and extensive research in recent
years.
[35]
The adhesion of bacteria to such
biopassive surfaces can be prevented by
decreasing the direct contact between them
and the surface. For this purpose, various
techniques have been adapted for the im-
mobilization of poly(ethylene glycol)
(PEG) on different surfaces.
[36,37]
Such
PEG-coated biomaterials were shown to
drastically decrease the amount of ad-
sorbed protein due to the formation of an
interfacial layerwithout directly interfering
with the microorganisms. This approach
was expanded by the introduction of cat-
echol moieties as anchoring groups.
[26–28]
The advantage of such a system is the fac-
ile functionalization of the surface, which
can be achieved by a simple dip-and-rinse
procedure in aqueous solution under cloud
point conditions.
[25,26,38,39]
Therefore, the
binding properties of the anachelin chro-
mophore were conjugated to the antifoul-
ing nature of PEG (Fig. 3, top left).
[26]
Upon
adsorption of the resulting PEG-anachelin
conjugate onto a TiO
2
plate, a very large
reduction of the protein adlayer thickness
of over 95% was observed upon exposure
to full human serum in comparison to un-
treated control surfaces. This strategy en-
abled the formation of a stable, protein-re-
sistant adlayer. The anchor moiety not only
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Fig. 3. Various antifouling and antibacterial coating agents.
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nitro-dopamine derivative due to the ease
of accessibility, strong binding properties
towardsmetal oxides, and stability towards
oxidation (Fig. 4).
A modified dip-and-rinse procedure
was applied for the immobilization of this
hybrid onto TiO
2
beads with an average di-
ameter of 1 µm. The immobilized modu-
lators proved to be the most sensitive for
the GFP-based biosensor P. putida F117
(pAS-C8),
[59]
having similar activity as the
natural agonist N-octanoyl-l-homoserine
lactone (C
8
-AHL, Fig. 4). The biologi-
cal activity could be preserved even after
extensive washing of the beads up to ten
times with water. The use of the beads
was especially advantageous, as the loca-
tion of the activated bacteria could be eas-
ily observed via fluorescence microscopy.
Induction of QS was observed in the entire
population and not only at the surface in-
terface (Fig. 5a and 5b), comparable with
the positive control using the free natural
agonist (Fig. 5c and 5d). On the other hand,
no GFP fluorescence could be observed in
the absence of a modulator in the nega-
tive control (Fig. 5e and 5f). The mode of
action was determined by performing di-
alysis assays using cellulose ester mem-
branes. While the beads are retained in
vent this problem, preparation of coated
implant surfaces via simple dip-and-rinse
procedures represents a far simpler method
of choice. Therefore, vancomycin, a well-
studied antibiotic agent frequently used
against bacterial infections, was chemical-
ly linked to the anachelin chromophore via
a PEG linker (Fig. 3, bottom).
[28]
This natu-
ral product hybrid delivers three different
properties: strong binding to the TiO
2
sur-
face through the anachelin chromophore
moiety, prevention of bacterial adhesion
onto the surface through the PEG linker,
and antiseptic properties against Gram-
positive bacteria through antibiotic vanco-
mycin. The resulting antimicrobial hybrids
were immobilized onto a TiO
2
surface via
our established and simple dip-coating
process. The functionalized surfaces were
shown to possess antibacterial activity
against Bacillus subtilis. Furthermore, the
obtained functionalized surfaces proved to
be recyclable, as they could be washed out
by rinsing with water and reused without
loss in antimicrobial activity. This hybrid
strategy could also be applied to other
antimicrobial agents. Even further, the
combination of different antibiotics on
biomedical surfaces could be achieved,
thereby broadening the application field.
However, investigations are required to
test if resistances of bacteria are developed
upon exposure and if accumulation of dead
bacteria on the coated surface will lead to
reduction of its antimicrobial activity over
a long period of time.
Quorum Sensing Modulating
Coating
A different approach to prevent bio-
film formation involves the inhibition of
the cell-to-cell communication pathway
of bacteria, known as quorum sensing
(QS).
[41–47]
Bacteria have evolved QS as
a fascinating communication system to
detect their local population density and
coordinate their gene expression. This sys-
tem is mediated by the exchange of small
signaling molecules, so-called autoinduc-
ers,
[48]
which are secreted and released by
the bacteria themselves. Various bacterial
functions are controlled by QS including
extracellular polymer production, surface
attachment, sporulation and the secretion
of virulence factors. Therefore, interfering
with theQSsystemcould inhibitbiofilmde-
velopment. This idea of preparing antibio-
film surfaces that inhibit the QS commu-
nication pathway was inspired by nature.
For instance, Delisea pulchra, a native red
algae from southeastern Australia, stores
anti-QS substances in vesicles situated
on the surface of the alga to inhibit bacte-
rial colonization. The secreted active com-
pounds consist of a range of halogenated
furanones called fimbrolides.
[49]
Several
synthetic methods have been investigated
to immobilize furanones on polymer ma-
terials to inhibit biofilm formation.
[50,51]
However, such furanones were also shown
to possess cytotoxic andmutagenic proper-
ties, thereby limiting their practical appli-
cations.
[52,53]
Alternative strategies based
on the molecular interference with QS
pathways have been explored to influence
the bacterial functions in order to inhibit
biofilm formation.
[54]
We have been partic-
ularly interested in Gram-negative bacte-
ria, as their QS system is mostly mediated
by the exchange of N-acyl-l-homoserine
lactones (AHLs).
[55–57]
Using an analogous
strategy to our previous approach, various
hybrids bearing an AHL moiety as recog-
nition pattern for the bacteria and different
anchor groups for the immobilization of
QS modulators directly onto TiO
2
surfaces
were designed and synthesized.
[39]
These
two fragments were connected by alkyl
linkers with various lengths. Preliminary
results with the AHL biosensor strain C.
violaceum CV026
[58]
showed good activ-
ity of all the hybrids bearing a C
12
alkyl
linker. Interestingly, the anchor group
had no impact on the activity. Therefore,
further studies were initiated using the
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Fig. 4. Nitro-
dopamine-containing
quorum sensing
modulating coating
agent and the natural
agonist C
8
-AHL.
Fig. 5. Phase contrast (a) and GFP fluorescence (b) of the sensor incubated with the functional-
ized beads. Phase contrast (c) and GFP fluorescence (d) of the sensor incubated with the natural
agonist C
8
-AHL as a positive control. Phase contrast (e) and GFP fluorescence (f) of the sensor
as a negative control. Fig. 5 reproduced from ref. [39] with permission of The Royal Society of
Chemistry.
(a) (c) (e)
(b) (d) (f)
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dialysis bags during this assay, released
hybrids can diffuse into the surrounding
medium and modulate QS in the biosen-
sor. Fluorescence was observed in the re-
porter strain situated on the outside of the
dialysis bags, showing that AHL mimics
are released from the beads. The observed
release was steady and a linear increase
of activity after overnight incubation was
monitored. Themechanism of release from
the surface is not yet fully understood and
is currently under investigation.
Conclusion
In conclusion, the preparation of bio-
active metal oxide surfaces can be easily
achieved through an operationally simple
dip-and-rinse procedure using dopamine-
based anchoring moieties. This approach
was successfully applied to the function-
alization of TiO
2
surfaces using different
bifunctional coating agents. The combi-
nation of the anachelin chromophore and
nitro-dopamine with PEG afforded an anti-
fouling agent, which could successfully be
immobilized and thereby render the coated
surface repellent against proteins and mi-
croorganisms. This method was expanded
by the covalent linkage of vancomycin to
PEG. The resulting surfaces showed anti-
bacterial properties, which could be pre-
served even after washing. Last, a quorum
sensing modulating coating agent could be
adsorbed on TiO
2
beads. These beads were
able to induce quorum sensing in the en-
tire bacterial population, which was shown
to occur upon slow release of the hybrids.
Again, the biological activity could be
preserved upon washing of the beads up
to ten times without significant observable
decrease. Such surfaces could not only find
applications in medicine, but also in agri-
culture and material sciences.
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